Description
Justification for Direct Award The Blood Bank is expanding its operations into new facilities and requires four new plasmapheresis instruments that must operate seamlessly with the existing ISO-certified solution based on Fresenius Kabi equipment integrated via DXT and ProSang. To the best of our knowledge, no other plasmapheresis instruments on the market today are technically compatible with the established middleware or capable of integrating directly with ProSang without development of a new integration solution. Operation of parallel systems is considered unacceptable due to increased risk, complexity, training needs, and significant additional operational and quality-related costs. Full replacement of the current equipment is also not feasible, as the existing machines have substantial remaining service life and represent major investments. See the attached document for a detailed justification. Based on this, it is assessed that only Fresenius Kabi Norway AS can supply plasmapheresis equipment that meets the Blood Bank’s technical requirements. Four (4) Aurora plasmapheresis instruments from Fresenius Kabi AS will therefore be procured. The conditions for a direct award without competition under FOA § 13-4 (2) are considered fulfilled. Competition is impossible for technical reasons. Any objections must be submitted to the project manager within 10 days after publication of the notice.
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile1 open tender right now
Recent awards
- Laboratory, optical and precision equipments (excl. glasses) - 78045 E2026 RA KRE KRF Flow cytometer
- Medical equipment, pharmaceuticals and personal care products - 77203 RH KLM PAT Immune colour machines V3
- Laboratory, optical and precision equipments (excl. glasses) - 78102 RA KRE KRF Automatic electrophores instruments for RNA and DNA (2 items)
Similar tenders
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €11,310,009
- Buyer track record on Aperlena
- 53 notices tracked · 25 awarded
- €33,211,765 in awarded contracts
Never miss a tender like this
14 new notices in Medical equipment & pharmaceuticals in Norway in the last 7 days. Get an email when new ones appear. Free.
Set up my alert